IP Library Granted Patent US 7,813,811
Granted Patent B2
US 7,813,811 · App. 11/704,534 · Granted Oct 12, 2010

Refillable reservoir lead systems

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,813,811
App. No.
11/704,534
Granted
Oct 12, 2010
Kind
B2
Abstract

Medical electrical lead systems and related methods are described. The medical electrical lead systems may be configured to be at least partially implanted in a body of a subject. Some variations of the medical electrical lead systems may comprise a lead body comprising a proximal end and a distal end and a lumen extending at least partially therebetween, at least one electrode in the proximity of the distal end of the lead body, and a reservoir in fluid communication with the lumen, where the reservoir is located at a position removed from the distal end of the lead body. Certain variations of the medical electrical lead systems may comprise a lead body comprising a proximal end and a distal end and first and second lumens extending at least partially therebetween, and at least one electrode in the proximity of the distal end of the lead body.

Claims (28)

1. A medical electrical lead system configured to be at least partially implanted in a body of a subject, comprising:

a lead body comprising a proximal end and a distal end and a first lumen extending at least partially therebetween;

at least one electrode in the proximity of the distal end of the lead body; and

a reservoir in fluid communication with the first lumen and in the form of a second lumen of the lead body or a protrusion extending from the first lumen of the lead body, wherein the protrusion is configured to be refilled whether the protrusion is implanted in the body of the subject or external to the body of the subject during use,

wherein the reservoir is located at a position removed from the distal end of the lead body.

2. The lead system of claim 1 , wherein the lead system is configured to be at least partially implanted in neural tissue of a subject.

3. The lead system of claim 2 , wherein the lead system is configured to be at least partially implanted in a brain of a subject.

4. The lead system of claim 1 , wherein the reservoir is located in the proximity of the proximal end of the lead body.

5. The lead system of claim 1 , wherein the reservoir is configured to be activated by a pump.

6. The lead system of claim 1 , wherein the reservoir is in the form of a protrusion extending from the first lumen of the lead body, wherein the protrusion is configured to be refilled whether the protrusion is implanted in the body of the subject or external to the body of the subject during use.

7. The lead system of claim 6 , wherein the protrusion extends from the first lumen of the lead body and surrounds a portion of the lead body.

8. The lead system of claim 1 , wherein the lead system is configured to allow at least one bioactive agent to passively advance from the reservoir through the first lumen of the lead body.

9. The lead system of claim 1 , wherein the lead system is configured for release of at least one bioactive agent therefrom by at least one of diffusion, elution, or effusion.

10. The lead system of claim 1 , wherein the reservoir is configured to be secured to a skull of a subject.

11. The lead system of claim 1 , further comprising at least one conductor disposed within the lead body.

12. The lead system of claim 11 , wherein the at least one conductor is wound around the first lumen.

13. The lead system of claim 12 , wherein the at least one conductor is coiled around the first lumen.

14. The lead system of claim 1 , wherein the distal end of the lead body is formed of at least one permeable material.

15. The lead system of claim 14 , wherein the proximal end of the lead body is formed of at least one substantially impermeable material.

16. The lead system of claim 1 , wherein the proximal end of the lead body is formed of at least one substantially impermeable material.

17. The lead system of claim 1 , wherein the lead system is configured to be connected to an implantable medical device.

18. The lead system of claim 1 , wherein the lead body is integral with the reservoir.

19. The lead system of claim 1 , wherein the reservoir is in the form of a second lumen of the lead body.

20. The lead system of claim 19 , wherein the reservoir is refillable.

21. The lead system of claim 1 , further comprising a valve located between the reservoir and the first lumen.

22. The lead system of claim 21 , wherein the valve comprises a check valve.

23. The lead system of claim 1 , wherein the reservoir comprises MRI-visible markers.

24. The lead system of claim 1 , wherein the reservoir comprises radiopaque markers.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jun 4, 2025
From: CRG SERVICING LLC AS SUCCESSOR TO CAPITAL ROYALTY PARTNERS II L.P., CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P., AND PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: NEUROPACE INC.
Reel/Frame 071495/0800 →
SECURITY INTEREST Recorded Sep 25, 2020
From: NEUROPACE, INC.
To: CRG SERVICING LLC
Reel/Frame 053885/0932 →
SHORT-FORM PATENT SECURITY AGREEMENT Recorded Nov 20, 2014
From: NEUROPACE, INC.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034410/0767 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 8, 2007
From: WINGEIER, BRETT M.; MORRELL, MARTHA J.; BOLING, C. LANCE
To: NEUROPACE, INC.
Reel/Frame 019263/0705 →